Compare BLTE & Z Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | Z |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 7.1B |
| IPO Year | 2021 | 2014 |
| Metric | BLTE | Z |
|---|---|---|
| Price | $147.72 | $32.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $228.89 | $41.83 |
| AVG Volume (30 Days) | 133.0K | ★ 4.2M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 118.75 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $1,076,794,000.00 |
| Revenue This Year | N/A | $14.05 |
| Revenue Next Year | N/A | $11.60 |
| P/E Ratio | ★ N/A | $189.36 |
| Revenue Growth | N/A | ★ 27.19 |
| 52 Week Low | $90.84 | $26.67 |
| 52 Week High | $200.00 | $78.06 |
| Indicator | BLTE | Z |
|---|---|---|
| Relative Strength Index (RSI) | 39.67 | 59.37 |
| Support Level | $145.21 | $29.49 |
| Resistance Level | $161.08 | $34.46 |
| Average True Range (ATR) | 5.89 | 1.49 |
| MACD | -0.37 | 0.73 |
| Stochastic Oscillator | 30.70 | 77.62 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Zillow Group Inc is a real estate technology company offering a digital platform that connects real estate customers with sellers, agents, loan officers, and other real estate-related professionals. With its tools and resources, Zillow helps real estate professionals grow their businesses, and for renters and housing providers, it offers a marketplace along with a set of end-to-end products and services to streamline applications, leases, payments, and more. The group operates various brands such as Zillow, Zillow Home Loans, Zillow Rentals, Zillow New Construction, Trulia, StreetEasy, Out East, HotPads, Follow Up Boss, ShowingTime, dotloop, and Zillow Closing. Its ecosystem spans the entire home journey from shopping to renting, buying, selling, and financing real estate.